<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39408623</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>DNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10293</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms251910293</ELocationID><Abstract><AbstractText>The ability of the SARS-CoV-2 virus to cause DNA damage in infected humans requires its study as a potential indicator of COVID-19 progression. DNA damage was studied in leukocytes of 65 COVID-19 patients stratified by sex, age, and disease severity in relation to demographic, clinical, and laboratory parameters. In a combined group of COVID-19 patients, DNA damage was shown to be elevated compared to controls (12.44% vs. 5.09%, <i>p</i> &lt; 0.05). Severe cases showed higher DNA damage than moderate cases (14.66% vs. 10.65%, <i>p</i> &lt; 0.05), and males displayed more damage than females (13.45% vs. 8.15%, <i>p</i> &lt; 0.05). DNA damage is also correlated with international normalized ratio (INR) (r = 0.471, <i>p</i> &lt; 0.001) and creatinine (r = 0.326, <i>p</i> &lt; 0.05). In addition to DNA damage, severe COVID-19 is associated with age, C-reactive protein (CRP), and creatinine. Receiver operating characteristic analysis identified age, INR, creatinine, DNA damage, and CRP as significant predictors of disease severity, with cut-off values of 72.50 years, 1.46 s, 78.0 µmol/L, 9.72%, and 50.0 mg/L, respectively. The results show that DNA damage correlates with commonly accepted COVID-19 risk factors. These findings underscore the potential of DNA damage as a biomarker for COVID-19 severity, suggesting its inclusion in prognostic assessments to facilitate early intervention and improve patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harutyunyan</LastName><ForeName>Tigran</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1613-1019</Identifier><AffiliationInfo><Affiliation>Laboratory of General and Molecular Genetics, Research Institute of Biology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Cytology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sargsyan</LastName><ForeName>Anzhela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2720-0355</Identifier><AffiliationInfo><Affiliation>Laboratory of General and Molecular Genetics, Research Institute of Biology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Cytology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalashyan</LastName><ForeName>Lily</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0004-0882-4984</Identifier><AffiliationInfo><Affiliation>Laboratory of General and Molecular Genetics, Research Institute of Biology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stepanyan</LastName><ForeName>Naira</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0006-6506-3813</Identifier><AffiliationInfo><Affiliation>National Center for Infectious Diseases, Arno Babajanyan 21, Yerevan 0064, Armenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aroutiounian</LastName><ForeName>Rouben</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1020-9513</Identifier><AffiliationInfo><Affiliation>Laboratory of General and Molecular Genetics, Research Institute of Biology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Cytology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liehr</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1672-3054</Identifier><AffiliationInfo><Affiliation>Jena University Hospital, Institute of Human Genetics, Friedrich Schiller University, Am Klinikum 1, D-07747 Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hovhannisyan</LastName><ForeName>Galina</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7450-1508</Identifier><AffiliationInfo><Affiliation>Laboratory of General and Molecular Genetics, Research Institute of Biology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Cytology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>21AG-1F068</GrantID><Agency>RA MESCS Science Committee</Agency><Country /></Grant><Grant><GrantID>22SC-BMBF-1C001</GrantID><Agency>RA MESCS Science Committee and German Federal Ministry of Education and Research</Agency><Country /></Grant><Grant><GrantID>01DK24003</GrantID><Agency>German Aerospace Center (Deutsches Forschungszentrum für Luft- und Raumfahrt, DLR)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019934" MajorTopicYN="N">International Normalized Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 virus</Keyword><Keyword MajorTopicYN="N">comet assay</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of this study, in the collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408623</ArticleId><ArticleId IdType="pmc">PMC11476890</ArticleId><ArticleId IdType="doi">10.3390/ijms251910293</ArticleId><ArticleId IdType="pii">ijms251910293</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . WHO COVID-19 Dashboard. World Health Organization; Geneva, Switzerland: 2024.</Citation></Reference><Reference><Citation>Wise J. COVID-19: WHO Declares End of Global Health Emergency. BMJ. 2023;381:10412023. doi: 10.1136/bmj.p1041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p1041</ArticleId><ArticleId IdType="pubmed">37160309</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E. WHO Declares End of COVID-19 Global Health Emergency. JAMA. 2023;329:1817. doi: 10.1001/jama.2023.8656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8656</ArticleId><ArticleId IdType="pubmed">37195734</ArticleId></ArticleIdList></Reference><Reference><Citation>Roknuzzaman A.S.M., Sarker R., Islam M.R. The World Health Organization Has Endorsed COVID-19 Is No Longer a Global Public Health Emergency: How They Took This Step and What We Should Do Right Now? Int. J. Health Plann. Manag. 2023;38:1595–1598. doi: 10.1002/hpm.3668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hpm.3668</ArticleId><ArticleId IdType="pubmed">37269486</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli A.M., Peacock T.P., Thorne L.G., Harvey W.T., Hughes J., de Silva T.I., Peacock S.J., Barclay W.S., de Silva T.I., Towers G.J., et al. SARS-CoV-2 Variant Biology: Immune Escape, Transmission and Fitness. Nat. Rev. Microbiol. 2023;21:162–177. doi: 10.1038/s41579-022-00841-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . COVID-19, W. Epidemiological Update—17 June 2024. World Health Organization; Geneva, Switzerland: 2024.</Citation></Reference><Reference><Citation>Sil D., Gautam S., Saxena S., Joshi S., Kumar D., Mehta A., Jindal P., Sharma S., Pandey P., Diksha, et al. Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global Impact. Curr. Drug Targets. 2024;25:517–525. doi: 10.2174/0113894501296586240430061915.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0113894501296586240430061915</ArticleId><ArticleId IdType="pubmed">38726782</ArticleId></ArticleIdList></Reference><Reference><Citation>Grand R.J. SARS-CoV-2 and the DNA Damage Response. J. Gen. Virol. 2023;104:001918. doi: 10.1099/jgv.0.001918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001918</ArticleId><ArticleId IdType="pmc">PMC10768691</ArticleId><ArticleId IdType="pubmed">37948194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovhannisyan G., Harutyunyan T., Aroutiounian R., Liehr T. The Diagnostic, Prognostic, and Therapeutic Potential of Cell-Free DNA with a Special Focus on COVID-19 and Other Viral Infections. Int. J. Mol. Sci. 2023;24:14163. doi: 10.3390/ijms241814163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241814163</ArticleId><ArticleId IdType="pmc">PMC10532175</ArticleId><ArticleId IdType="pubmed">37762464</ArticleId></ArticleIdList></Reference><Reference><Citation>Papanikolaou C., Rapti V., Stellas D., Stefanou D.T., Syrigos K., Pavlakis G.N., Souliotis V.L. Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network. Vaccines. 2022;10:1764. doi: 10.3390/vaccines10101764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101764</ArticleId><ArticleId IdType="pmc">PMC9610764</ArticleId><ArticleId IdType="pubmed">36298629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekawy A.S., Alaswad Z., Ibrahim A.A., Mohamed A.A., AlOkda A., Elserafy M. The Consequences of Viral Infection on Host DNA Damage Response: A Focus on SARS-CoVs. J. Genet. Eng. Biotechnol. 2022;20:104. doi: 10.1186/s43141-022-00388-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43141-022-00388-3</ArticleId><ArticleId IdType="pmc">PMC9277982</ArticleId><ArticleId IdType="pubmed">35829826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioia U., Tavella S., Martínez-Orellana P., Cicio G., Colliva A., Ceccon M., Cabrini M., Henriques A.C., Fumagalli V., Paldino A., et al. SARS-CoV-2 Infection Induces DNA Damage, through CHK1 Degradation and Impaired 53BP1 Recruitment, and Cellular Senescence. Nat. Cell Biol. 2023;25:550–564. doi: 10.1038/s41556-023-01096-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-023-01096-x</ArticleId><ArticleId IdType="pmc">PMC10104783</ArticleId><ArticleId IdType="pubmed">36894671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihaljevic O., Zivancevic-Simonovic S., Cupurdija V., Marinkovic M., Vukajlovic J.T., Markovic A., Stanojevic-Pirkovic M., Milosevic-Djordjevic O. DNA Damage in Peripheral Blood Lymphocytes of Severely Ill COVID-19 Patients in Relation to Inflammatory Markers and Parameters of Hemostasis. Mutagenesis. 2022;37:203–212. doi: 10.1093/mutage/geac011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mutage/geac011</ArticleId><ArticleId IdType="pmc">PMC9129204</ArticleId><ArticleId IdType="pubmed">35524945</ArticleId></ArticleIdList></Reference><Reference><Citation>Basaran M.M., Hazar M., Aydın M., Uzuğ G., Özdoğan İ., Pala E., Aydın Dilsiz S., Basaran N. Effects of COVID-19 Disease on DNA Damage, Oxidative Stress and Immune Responses. Toxics. 2023;11:386. doi: 10.3390/toxics11040386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxics11040386</ArticleId><ArticleId IdType="pmc">PMC10145820</ArticleId><ArticleId IdType="pubmed">37112613</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektemur G., Bozali K., Colak S., Aktas S., Guler E.M. Oxidative Stress, DNA Damage, and Inflammation in COVID-19 Patients. North. Clin. Istanbul. 2023;10:335–340. doi: 10.14744/nci.2022.00947.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/nci.2022.00947</ArticleId><ArticleId IdType="pmc">PMC10331251</ArticleId><ArticleId IdType="pubmed">37435296</ArticleId></ArticleIdList></Reference><Reference><Citation>Doğan H., Kara A., Çankaya E., Balkan E., Gürbüz M.A., Kızılkaya M., Aykaç M. Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients. Curr. Issues Mol. Biol. 2023;45:963–974. doi: 10.3390/cimb45020062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb45020062</ArticleId><ArticleId IdType="pmc">PMC9955698</ArticleId><ArticleId IdType="pubmed">36826007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tepebaşı M.Y., İlhan İ., Temel E.N., Sancer O., Öztürk Ö. Investigation of Inflammation, Oxidative Stress, and DNA Damage in COVID-19 Patients. Cell Stress Chaperones. 2023;28:191–199. doi: 10.1007/s12192-023-01330-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-023-01330-3</ArticleId><ArticleId IdType="pmc">PMC9936118</ArticleId><ArticleId IdType="pubmed">36797451</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Agnillo F., Walters K.A., Xiao Y., Sheng Z.M., Scherler K., Park J., Gygli S., Rosas L.A., Sadtler K., Kalish H., et al. Lung Epithelial and Endothelial Damage, Loss of Tissue Repair, Inhibition of Fibrinolysis, and Cellular Senescence in Fatal COVID-19. Sci. Transl. Med. 2021;13:eabj7790. doi: 10.1126/scitranslmed.abj7790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulasinghe A., Liu N., Tan C.W., Monkman J., Sinclair J.E., Bhuva D.D., Godbolt D., Pan L., Nam A., Sadeghirad H., et al. Transcriptomic Profiling of Cardiac Tissues from SARS-CoV-2 Patients Identifies DNA Damage. Immunology. 2023;168:403–419. doi: 10.1111/imm.13577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13577</ArticleId><ArticleId IdType="pmc">PMC9537957</ArticleId><ArticleId IdType="pubmed">36107637</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor J., Deutsch J., Whitaker A., Lamkin E.N., March A., Zhou P., Botten J.W., Chatterjee N. SARS-CoV-2 Triggers DNA Damage Response in Vero E6 Cells. Biochem. Biophys. Res. Commun. 2021;579:141–145. doi: 10.1016/j.bbrc.2021.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.09.024</ArticleId><ArticleId IdType="pmc">PMC8440005</ArticleId><ArticleId IdType="pubmed">34600299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H., Ma C., Peng H., Zhang B., Zhou L., Su Y., Gao X., Huang H. Micronucleus Production, Activation of DNA Damage Response and CGAS-STING Signaling in Syncytia Induced by SARS-CoV-2 Infection. Biol. Direct. 2021;16:20. doi: 10.1186/s13062-021-00305-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-021-00305-7</ArticleId><ArticleId IdType="pmc">PMC8530504</ArticleId><ArticleId IdType="pubmed">34674770</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira Gonçalves S., da Luz T.M., Silva A.M., de Souza S.S., Montalvão M.F., Guimarães A.T.B., Ahmed M.A.I., da Costa Araújo A.P., Karthi S., Malafaia G. Can Spike Fragments of SARS-CoV-2 Induce Genomic Instability and DNA Damage in the Guppy, Poecilia Reticulate? An Unexpected Effect of the COVID-19 Pandemic. Sci. Total Environ. 2022;825:153988. doi: 10.1016/j.scitotenv.2022.153988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2022.153988</ArticleId><ArticleId IdType="pmc">PMC8857768</ArticleId><ArticleId IdType="pubmed">35192827</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahankhani K., Ahangari F., Adcock I.M., Mortaz E. Possible Cancer-Causing Capacity of COVID-19: Is SARS-CoV-2 an Oncogenic Agent? Biochimie. 2023;213:130–138. doi: 10.1016/j.biochi.2023.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2023.05.014</ArticleId><ArticleId IdType="pmc">PMC10202899</ArticleId><ArticleId IdType="pubmed">37230238</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir C.B., Jan A. BMI Classification Percentile and Cut Off Points. StatPearls; Treasure Island, FL, USA: 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31082114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui S., Ikeda K., Kobayashi M., Nishida K., Yamada K., Horie S., Shimada Y., Miki H., Goto H., Hayashi K., et al. Predictive Prognostic Biomarkers in Patients with COVID-19 Infection. Mol. Med. Rep. 2023;27:15. doi: 10.3892/mmr.2022.12902.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2022.12902</ArticleId><ArticleId IdType="pubmed">36453231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.J., Dong X., Liu G.H., Gao Y.D. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clin. Rev. Allergy Immunol. 2023;64:90–107. doi: 10.1007/s12016-022-08921-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Martono, Fatmawati F., Mulyanti S. Risk Factors Associated with the Severity of COVID-19. Malays. J. Med. Sci. 2023;30:84–92. doi: 10.21315/mjms2023.30.3.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.21315/mjms2023.30.3.7</ArticleId><ArticleId IdType="pmc">PMC10325129</ArticleId><ArticleId IdType="pubmed">37425387</ArticleId></ArticleIdList></Reference><Reference><Citation>Milić M., Ceppi M., Bruzzone M., Azqueta A., Brunborg G., Godschalk R., Koppen G., Langie S., Møller P., Teixeira J.P., et al. The HCOMET Project: International Database Comparison of Results with the Comet Assay in Human Biomonitoring. Baseline Frequency of DNA Damage and Effect of Main Confounders. Mutat. Res. Rev. Mutat. Res. 2021;787:108371. doi: 10.1016/j.mrrev.2021.108371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2021.108371</ArticleId><ArticleId IdType="pmc">PMC8525632</ArticleId><ArticleId IdType="pubmed">34083035</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W., Qiu Z., Zhou L., Hou J., Wang Y., Huang F., Zhang Y., Jia Y., Zhou J., Liu D., et al. Sex Differences in Clinical Characteristics and Risk Factors for Mortality among Severe Patients with COVID-19: A Retrospective Study. Aging. 2020;12:18833–18843. doi: 10.18632/aging.103793.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103793</ArticleId><ArticleId IdType="pmc">PMC7732274</ArticleId><ArticleId IdType="pubmed">33051404</ArticleId></ArticleIdList></Reference><Reference><Citation>Haitao T., Vermunt J.V., Abeykoon J., Ghamrawi R., Gunaratne M., Jayachandran M., Narang K., Parashuram S., Suvakov S., Garovic V.D. COVID-19 and Sex Differences: Mechanisms and Biomarkers. Mayo Clin. Proc. 2020;95:2189–2203. doi: 10.1016/j.mayocp.2020.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.07.024</ArticleId><ArticleId IdType="pmc">PMC7402208</ArticleId><ArticleId IdType="pubmed">33012349</ArticleId></ArticleIdList></Reference><Reference><Citation>Brest P., Refae S., Mograbi B., Hofman P., Milano G. Host Polymorphisms May Impact SARS-CoV-2 Infectivity. Trends Genet. 2020;36:813–815. doi: 10.1016/j.tig.2020.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7416730</ArticleId><ArticleId IdType="pubmed">32828550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto T.G., Alpire M.E.S., Ribeiro D.A. Cytogenetic Biomonitoring in Buccal Mucosa Cells of COVID-19 Patients: Preliminary Findings. In Vivo. 2021;35:3495–3499. doi: 10.21873/invivo.12651.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12651</ArticleId><ArticleId IdType="pmc">PMC8627778</ArticleId><ArticleId IdType="pubmed">34697187</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddoze C., Morange S., Portugal H., Berland Y., Dussol B. Comet-Assay Analysis Identifies Genomic Damage in Lymphocytes of Uremic Patients. Am. J. Kidney Dis. 2001;38:296–301. doi: 10.1053/ajkd.2001.26094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2001.26094</ArticleId><ArticleId IdType="pubmed">11479155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel-López A., Paniagua-Medina M.E., Urbán-Reyes M., Cortes-Arredondo M., Álvarez-Aguilar C., López-Meza J., Ochoa-Zarzosa A., Lindholm B., García-López E., Paniagua J.R. Genetic Damage in Patients with Chronic Kidney Disease, Peritoneal Dialysis and Haemodialysis: A Comparative Study. Mutagenesis. 2013;28:219–225. doi: 10.1093/mutage/ges075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mutage/ges075</ArticleId><ArticleId IdType="pmc">PMC3570793</ArticleId><ArticleId IdType="pubmed">23408844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan E.L., Hollingworth R., Grand R.J. Activation of the DNA Damage Response by RNA Viruses. Biomolecules. 2016;6:2. doi: 10.3390/biom6010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom6010002</ArticleId><ArticleId IdType="pmc">PMC4808796</ArticleId><ArticleId IdType="pubmed">26751489</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.T.T., Park E.-M., Lim Y.-S., Hwang S.B. Nonstructural Protein 5A Impairs DNA Damage Repair: Implications for Hepatitis C Virus-Mediated Hepatocarcinogenesis. J. Virol. 2018;92:e00178-18. doi: 10.1128/JVI.00178-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00178-18</ArticleId><ArticleId IdType="pmc">PMC5952158</ArticleId><ArticleId IdType="pubmed">29563287</ArticleId></ArticleIdList></Reference><Reference><Citation>Pánico P., Ostrosky-Wegman P., Salazar A.M. The Potential Role of COVID-19 in the Induction of DNA Damage. Mutat. Res. Rev. Mutat. Res. 2022;789:108411. doi: 10.1016/j.mrrev.2022.108411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2022.108411</ArticleId><ArticleId IdType="pmc">PMC8767986</ArticleId><ArticleId IdType="pubmed">35690420</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A., Barbi V., Zamperla M.G., Atlante S., Forleo L., Nesta M., Massetti M., Pontecorvi A., Nanni S., Farsetti A., et al. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. Int. J. Mol. Sci. 2021;22:6151. doi: 10.3390/ijms22116151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116151</ArticleId><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Richards A., Inmaculada Barrasa M., Hughes S.H., Young R.A., Jaenisch R. Reverse-Transcribed SARS-CoV-2 RNA Can Integrate into the Genome of Cultured Human Cells and Can Be Expressed in Patient-Derived Tissues. Proc. Natl. Acad. Sci. USA. 2021;118:e2105968118. doi: 10.1073/pnas.2105968118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldén M., Olofsson Falla F., Yang D., Barghouth M., Luan C., Rasmussen M., De Marinis Y. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 MRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022;44:1115–1126. doi: 10.3390/cimb44030073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44030073</ArticleId><ArticleId IdType="pmc">PMC8946961</ArticleId><ArticleId IdType="pubmed">35723296</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Ma Y., Chang W. SARS-CoV-2 and the Nucleus. Int. J. Biol. Sci. 2022;18:4731–4743. doi: 10.7150/ijbs.72482.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.72482</ArticleId><ArticleId IdType="pmc">PMC9305274</ArticleId><ArticleId IdType="pubmed">35874947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Cruz-cosme R., Zhuang M.W., Liu D., Liu Y., Teng S., Wang P.H., Tang Q. A Systemic and Molecular Study of Subcellular Localization of SARS-CoV-2 Proteins. Signal Transduct. Target. Ther. 2020;5:269. doi: 10.1038/s41392-020-00372-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00372-8</ArticleId><ArticleId IdType="pmc">PMC7670843</ArticleId><ArticleId IdType="pubmed">33203855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundura L., Gimenez S., Cezar R., André S., Younas M., Lin Y.L., Portalès P., Lozano C., Boulle C., Reynes J., et al. Angiotensin II Induces Reactive Oxygen Species, DNA Damage, and T-Cell Apoptosis in Severe COVID-19. J. Allergy Clin. Immunol. 2022;150:594–603.e2. doi: 10.1016/j.jaci.2022.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.06.020</ArticleId><ArticleId IdType="pmc">PMC9278992</ArticleId><ArticleId IdType="pubmed">35841981</ArticleId></ArticleIdList></Reference><Reference><Citation>Molani S., Hernandez P.V., Roper R.T., Duvvuri V.R., Baumgartner A.M., Goldman J.D., Ertekin-Taner N., Funk C.C., Price N.D., Rappaport N., et al. Risk Factors for Severe COVID-19 Differ by Age for Hospitalized Adults. Sci. Rep. 2022;12:6568. doi: 10.1038/s41598-022-10344-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10344-3</ArticleId><ArticleId IdType="pmc">PMC9050669</ArticleId><ArticleId IdType="pubmed">35484176</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Rathore S.S., Khan H., Karale S., Chawla Y., Iqbal K., Bhurwal A., Tekin A., Jain N., Mehra I., et al. Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression. Front. Endocrinol. 2022;13:780872. doi: 10.3389/fendo.2022.780872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.780872</ArticleId><ArticleId IdType="pmc">PMC9205425</ArticleId><ArticleId IdType="pubmed">35721716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu A., Paliogiannis P., Carru C., Mangoni A.A. INR and COVID-19 Severity and Mortality: A Systematic Review with Meta-Analysis and Meta-Regression. Adv. Med. Sci. 2021;66:372–380. doi: 10.1016/j.advms.2021.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advms.2021.07.009</ArticleId><ArticleId IdType="pmc">PMC8292100</ArticleId><ArticleId IdType="pubmed">34315012</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaal A., Abu-Elfatth A., Bakkar L.M., El-Azeem H.G.A., Hetta H.F., Badawy E.R. Assessment of COVID -19 Associated Coagulopathy and Multiple Hemostatic Markers: A Single Center Study in Egypt. Infection. 2023;51:655–664. doi: 10.1007/s15010-022-01917-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01917-5</ArticleId><ArticleId IdType="pmc">PMC9510359</ArticleId><ArticleId IdType="pubmed">36138306</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A., Pisaturo M., Monari C., Ciminelli F., Maggi P., Allegorico E., Gentile I., Sangiovanni V., Esposito V., Gentile V., et al. Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19—An Observational Retrospective Study. Pathogens. 2023;12:973. doi: 10.3390/pathogens12080973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12080973</ArticleId><ArticleId IdType="pmc">PMC10459783</ArticleId><ArticleId IdType="pubmed">37623933</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah A.J., Arif A.T., Rahman H.A., Sofihussein K.Q., Hadi J.M., Aziz J.M.A., Tofiq S.S., Mustafa A.M. Assessing Serum C-Reactive Protein as a Predictor of COVID-19 Outcomes: A Retrospective Cross-Sectional Study. Ann. Med. Surg. 2023;85:3359–3363. doi: 10.1097/MS9.0000000000000761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MS9.0000000000000761</ArticleId><ArticleId IdType="pmc">PMC10328585</ArticleId><ArticleId IdType="pubmed">37427205</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R., Han C., Pei S., Yin M., Chen X. Procalcitonin Levels in COVID-19 Patients. Int. J. Antimicrob. Agents. 2020;56:106051. doi: 10.1016/j.ijantimicag.2020.106051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106051</ArticleId><ArticleId IdType="pmc">PMC7286278</ArticleId><ArticleId IdType="pubmed">32534186</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui J., Noubouossie D.F., Gandotra S., Cao L. Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients. Front. Cell. Infect. Microbiol. 2021;11:734005. doi: 10.3389/fcimb.2021.734005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.734005</ArticleId><ArticleId IdType="pmc">PMC8369350</ArticleId><ArticleId IdType="pubmed">34414135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kangro K., Wolberg A.S., Flick M.J. Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19. Curr. Drug Targets. 2022;23:1593–1602. doi: 10.2174/1389450123666220826162900.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450123666220826162900</ArticleId><ArticleId IdType="pmc">PMC10316333</ArticleId><ArticleId IdType="pubmed">36029073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F., Huang Y., Guo Y., Yin M., Chen X., Xiao L., Deng G. Association of Inflammatory Markers with the Severity of COVID-19: A Meta-Analysis. Int. J. Infect. Dis. 2020;96:467–474. doi: 10.1016/j.ijid.2020.05.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.055</ArticleId><ArticleId IdType="pmc">PMC7233226</ArticleId><ArticleId IdType="pubmed">32425643</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto T.I., Japar K.V., Kwenandar F., Damay V., Siregar J.I., Lugito N.P.H., Tjiang M.M., Kurniawan A. Inflammatory and Hematologic Markers as Predictors of Severe Outcomes in COVID-19 Infection: A Systematic Review and Meta-Analysis. Am. J. Emerg. Med. 2021;41:110–119. doi: 10.1016/j.ajem.2020.12.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.12.076</ArticleId><ArticleId IdType="pmc">PMC7831442</ArticleId><ArticleId IdType="pubmed">33418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Karn E., Trivedi K., Kumar P., Chauhan G., Kumari A., Pant P., Munisamy M., Prakash J., Sarkar P.G., et al. Procalcitonin as a Predictive Marker in COVID-19: A Systematic Review and Meta-Analysis. PLoS ONE. 2022;17:e0272840. doi: 10.1371/journal.pone.0272840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272840</ArticleId><ArticleId IdType="pmc">PMC9462680</ArticleId><ArticleId IdType="pubmed">36084093</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal S., Sengupta S., Lahiri S., Ghosh A., Bhowmick K. Role of Biomarkers in Prognostication of Moderate and Severe COVID-19 Cases. J. Fam. Med. Prim. Care. 2023;12:3186–3193. doi: 10.4103/jfmpc.jfmpc_423_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_423_23</ArticleId><ArticleId IdType="pmc">PMC10866217</ArticleId><ArticleId IdType="pubmed">38361890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay J., Thadhani E., Samson L., Engelward B. Inflammation-Induced DNA Damage, Mutations and Cancer. DNA Repair. 2019;83:102673. doi: 10.1016/j.dnarep.2019.102673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2019.102673</ArticleId><ArticleId IdType="pmc">PMC6801086</ArticleId><ArticleId IdType="pubmed">31387777</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezone A., Olivieri F., Napoli M.V., Procopio A., Avvedimento E.V., Gabrielli A. Inflammation and DNA Damage: Cause, Effect or Both. Nat. Rev. Rheumatol. 2023;19:200–211. doi: 10.1038/s41584-022-00905-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-022-00905-1</ArticleId><ArticleId IdType="pubmed">36750681</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Li L., Xu M.D., Wu J., Luo D., Zhu Y.S., Li B.X., Song X.Y., Zhou X. Prognostic Value of Interleukin-6, C-Reactive Protein, and Procalcitonin in Patients with COVID-19. J. Clin. Virol. 2020;127:104370. doi: 10.1016/j.jcv.2020.104370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104370</ArticleId><ArticleId IdType="pmc">PMC7194648</ArticleId><ArticleId IdType="pubmed">32344321</ArticleId></ArticleIdList></Reference><Reference><Citation>Pál K., Molnar A.A., Huțanu A., Szederjesi J., Branea I., Timár Á., Dobreanu M. Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients. Int. J. Mol. Sci. 2022;23:10423. doi: 10.3390/ijms231810423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231810423</ArticleId><ArticleId IdType="pmc">PMC9499352</ArticleId><ArticleId IdType="pubmed">36142336</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls B.G., Jolani S., Atherley A., Derckx R.T., Dijkstra J.I.R., Franssen G.H.L., Hendriks S., Richters A., Venemans-Jellema A., Zalpuri S., et al. Demographic Risk Factors for COVID-19 Infection, Severity, ICU Admission and Death: A Meta-Analysis of 59 Studies. BMJ Open. 2021;11:e044640. doi: 10.1136/bmjopen-2020-044640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044640</ArticleId><ArticleId IdType="pmc">PMC7802392</ArticleId><ArticleId IdType="pubmed">33431495</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeroto A.Y., Soetedjo N.N., Purwiga A., Santoso P., Kulsum I.D., Suryadinata H., Ferdian F. Effect of Increased BMI and Obesity on the Outcome of COVID-19 Adult Patients: A Systematic Review and Meta-Analysis. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:1897–1904. doi: 10.1016/j.dsx.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.09.029</ArticleId><ArticleId IdType="pmc">PMC7521380</ArticleId><ArticleId IdType="pubmed">33007661</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Living Guidance for Clinical Management of COVID-19. World Health Organization; Geneva, Switzerland: 2021. p. 63.</Citation></Reference><Reference><Citation>Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A Simple Technique for Quantitation of Low Levels of DNA Damage in Individual Cells. Exp. Cell Res. 1988;175:184–191. doi: 10.1016/0014-4827(88)90265-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4827(88)90265-0</ArticleId><ArticleId IdType="pubmed">3345800</ArticleId></ArticleIdList></Reference><Reference><Citation>Azqueta A., Collins A.R. The Essential Comet Assay: A Comprehensive Guide to Measuring DNA Damage and Repair. Arch. Toxicol. 2013;87:949–968. doi: 10.1007/s00204-013-1070-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-013-1070-0</ArticleId><ArticleId IdType="pubmed">23685795</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D., Chen M., Huang X., Zhang G., Zeng L., Zhang G., Wu S., Wang Y. SRplot: A Free Online Platform for Data Visualization and Graphing. PLoS ONE. 2023;18:e0294236. doi: 10.1371/journal.pone.0294236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0294236</ArticleId><ArticleId IdType="pmc">PMC10635526</ArticleId><ArticleId IdType="pubmed">37943830</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>